Logo Image
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Antibiotics Deconstructed
Clinical Forum Insights

Subscribe

  • News
  • Watch
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Vaccines in America|
Antibiotics Deconstructed|
Bench to Bedside With SIDP|
Antimicrobial Stewardship|
Hepatitis
Advertisement

ELIZABETH HIRSCH, PHARMD, RPH

Advertisement

Articles by ELIZABETH HIRSCH, PHARMD, RPH

What's New from the CLSI Subcommittee on Antimicrobial Susceptibility Testing?

ByELIZABETH HIRSCH, PHARMD, RPH
August 13th 2018

In addition to other updates, new breakpoints have been added for cefiderocol and meropenem-vaborbactam.

Advertisement

Latest Updated Articles

  • What's New from the CLSI Subcommittee on Antimicrobial Susceptibility Testing?
    What's New from the CLSI Subcommittee on Antimicrobial Susceptibility Testing?

    August 13th 2018



Advertisement
Advertisement

Trending on Contagion Live

1

Early Dual Therapy Shortens Staphylococcus aureus Bacteremia in SABEDTIO Trial

2

Pritelivir Cuts Hospital Days in Refractory HSV in Phase 3 PRIOH-1

3

Ebola Update: DRC Outbreak Reaches 9735 Cases, Second Largest on Record

4

IDSA 2026 Guidance Makes Sulbactam-Durlobactam the Priority for CRAB Infections

5

Novel RSV Therapy: Addressing a Clinical Need

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us